news

Beko Recognised as One of TIME Magazine’s Most Sustainable Companies in the World 2025

Holding the top spot in its industry, the company makes its second appearance on the list. ISTANBUL, July 7, 2025…

8 months ago

Runwal Raaya Hosts an Immersive Evening with Tao Art Gallery

Runwal Raaya transforms into a canvas for contemporary Indian artBollywood's Neha Dhupia & Angad Bedi grace the immersive showcaseAn evening…

8 months ago

NYSE Content advisory: Pre-Market update + Trump tariffs to resume Aug. 1

NEW YORK, July 7, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

8 months ago

DXC Technology Appoints Professional Services Industry Veteran Ramnath Venkataraman as President of Consulting & Engineering Services

ASHBURN, Va., July 7, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced…

8 months ago

beGalileo Deepens School Impact with Navneet, Expands Inclusive Learning Through Endeavor ELS Partnership

BENGALURU, India, July 7, 2025 /PRNewswire/ -- beGalileo, the Bangalore-based EdTech company and one of India's early pioneers in AI-driven…

8 months ago

Hisense Makes Home Smarter to Help Fans ‘Own the Moment’ During FIFA Club World Cup 2025

QINGDAO, China, July 7, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, is empowering…

8 months ago

Glow & Lovely Launches ‘Apni Roshni Baahar La’, a Nationwide Movement to Empower Women to Lead, Influence and Shine

Introduces 'The Glow Up Academy' with the ambition to nurture one digital creator in every PIN code across India MUMBAI,…

8 months ago

UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

8 months ago

LENZ Therapeutics and Laboratoires Tha Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties on net…

8 months ago

KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)

July 07, 2025 08:00 ET  | Source: KALA BIO, Inc. ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO,…

8 months ago